Daniel N. Swisher, Jr.

President & Chief Operating Officer at Jazz Pharmaceuticals Plc

Daniel N. Swisher, Jr.

Daniel N. Swisher, Jr.

President & Chief Operating Officer at Jazz Pharmaceuticals Plc

Overview
Career Highlights

Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
Sunesis Pharmaceuticals, Inc.

RelSci Relationships

876

Number of Boards

5

Birthday

1963

Age

56

Contact Data
Trying to get in touch with Daniel N. Swisher, Jr.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Daniel N. Swisher, Jr. likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Jazz Pharmaceuticals, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Cerus Corp.

Relationship likelihood: Strong

President, Research & Development, Senior Vice President & Chief Scientific Officer at Amarin Corporation Plc

Relationship likelihood: Strong

Venture Partner at 5AM Venture Management LLC

Relationship likelihood: Strong

Senior Advisor, Finance at Crinetics Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Scientific Officer at Cerus Corp.

Relationship likelihood: Strong

Co-Founder at Corcept Therapeutics, Inc.

Relationship likelihood: Strong

Partner at Venrock Associates

Relationship likelihood: Strong

Consultant at Sunesis Pharmaceuticals, Inc.

Relationship likelihood: Strong

Partner at Sutter Hill Ventures LLC

Relationship likelihood: Strong

Paths to Daniel N. Swisher, Jr.
Potential Connections via
Relationship Science
You
Daniel N. Swisher, Jr.
President & Chief Operating Officer at Jazz Pharmaceuticals Plc
Education
B.A.

Yale University is an American private Ivy League research university located in New Haven, Connecticut. Founded in 1701 in the Colony of Connecticut, the university is the third-oldest institution of higher education in the United States.

M.B.A.

The Stanford Graduate School of Business has built an international reputation based on its innovative programs, which include: Two-year MBA Program, designed to educate business leaders One-year Stanford Sloan Master’s Program for mid-career executives PhD Program for future academics Executive Education programs for experienced managers Faculty research program Academic programs, including the two-year MBA, the 12-month Sloan Master's Program, and the PhD program, create a transformational student experience that reflects the tagline: Change lives. Change organizations. Change the world. Today the state-of-the-art Knight Management Center complex enables Stanford's innovative, globalized MBA curriculum, offering flexible classroom spaces for hands-on experiential learning small-group leadership labs, and team-based learning. It engages faculty and students across Stanford University, as well as alumni, global executives, and the broader world community.

Career History
President & Chief Operating Officer
2018 - Current

• About Us • Mission & Values • Management Team • Board of Directors • Board Committees • Commercial Capabilities • Corporate Responsibility • Ethical Sales & Marketing • Drug Safety & Medical Info • Physician Data Restriction Program • California Compliance Declaration • Stories • What’s in a Name? • Business Development • Locations ABOUT US Jazz Pharmaceuticals plc is an international specialty biopharmaceutical company dedicated to helping patients with unmet medical needs. We identify, develop and commercialize innovative products in focused therapeutic areas, with a strong commercial focus and expertise in narcolepsy, oncology, pain and psychiatry. Our marketed product portfolio includes: XYREM® (sodium oxybate), ERWINAZETM (asparaginase Erwinia chrysanthemi), PRIALT® (ziconotide) solution, intrathecal infusion, FAZACLO® (clozapine, USP) LD and HD , and LUVOX CR® (fluvoxamine maleate). The product information on XYREM, ERWINAZE, PRIALT, FAZACLO LD, FAZACLO HD and LUVOX CR is intended only for residents of the United States. For more information, including complete prescribing information and boxed warnings, click on the product names above. Please visit www.EUSAPharma.com for more information about our international division, EUSA Pharma, and our products marketed outside the U.S. We plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our unique commercial expertise. As we evaluate additional acquisition and in-licensing opportunities, we work closely with healthcare professionals and patient advocates to identify significant treatment gaps where Jazz Pharmaceuticals’ unique approach to patient care and patient-focused products may be able to bring a new therapeutic option to the market where none existed previously.

President & Chief Operating Officer
2017 - Current

Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ.

President, Chief Executive Officer, Secretary & Director
2001 - 2017

Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Its efforts are currently focused primarily on the development of vosaroxin for the treatment of acute myeloid leukemia. The firms activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA.

Boards & Committees
Member, Board of Directors
2015 - Current

Corcept Therapeutics, Inc. engages in the development of drugs for the treatment of severe psychiatric, neurological, and metabolic disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.

Chair, Board of Directors
2011 - Current

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. It produces blood system for platelets and plasma. It markets its products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Strategic Advisor, Board of Directors
2003 - 2018

Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Its efforts are currently focused primarily on the development of vosaroxin for the treatment of acute myeloid leukemia. The firms activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA.

Director
2007 - Current

TO PROVIDE MENTORING, PEER SUPPORT, RESPITE AND RECREATIONAL PROGRAMS FOR ALL MEMBERS OF FAMILIES AFFECTED BY CHILDHOOD CANCER.

Council Member-1954
Tenure Unconfirmed
Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
N/A
2005

The Stanford Graduate School of Business has built an international reputation based on its innovative programs, which include: Two-year MBA Program, designed to educate business leaders One-year Stanford Sloan Master’s Program for mid-career executives PhD Program for future academics Executive Education programs for experienced managers Faculty research program Academic programs, including the two-year MBA, the 12-month Sloan Master's Program, and the PhD program, create a transformational student experience that reflects the tagline: Change lives. Change organizations. Change the world. Today the state-of-the-art Knight Management Center complex enables Stanford's innovative, globalized MBA curriculum, offering flexible classroom spaces for hands-on experiential learning small-group leadership labs, and team-based learning. It engages faculty and students across Stanford University, as well as alumni, global executives, and the broader world community.

Political Donations
$250
2014

Representative at Office of the Representative from California's 18th District, Anna Eshoo

$250
2009

Representative at Office of the Representative from California's 18th District, Anna Eshoo

$250
2006

Representative at Office of the Representative from California's 18th District, Anna Eshoo

Transactions
Details Hidden

Sunesis Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Sunesis Pharmaceuticals, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
Events
Speaker
New York City, NY
2013 UBS Global Healthcare Conference

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Daniel N. Swisher, Jr.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Daniel N. Swisher, Jr.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Daniel N. Swisher, Jr..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/daniel-n-swisher-jr-3383081
  • https://relationshipscience.com/person/daniel-n-swisher-jr-3383081